NCT01630239已完成早期 1 期
Technical Success, Safety, and Short-term Efficacy for MR-Guided Laser Ablation of Hepatic Tumors
适应症
试验速览
- 阶段
- 早期 1 期
- 状态
- 已完成
- 发起方
- Mayo Clinic
- 入组人数
- 1
- 试验地点
- 2
- 主要终点
- MR Images
研究概览
简要总结
This is a pilot study to investigate the performance of MR-guided Laser Induced Thermal Therapy (LITT) in the treatment of liver tumors.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with soft tissue tumor metastases to the liver who are referred to Interventional Radiology for treatment.
- •Surgery is not a viable or desirable alternative therapy at the time of enrollment
- •Radiation therapy has failed or not indicated or can be safely postponed
- •Tumor size ≤ 5 cm at its largest diameter
- •Tumor position is not in the central liver hilum
- •Performance status is ECOG 2 or better in adults
- •Patient is able to undergo MRI
排除标准
- •Patients with pacemaker or defibrillator
- •Patients with metallic surgical clips close to the site of the intended ablation
- •Pregnant women
- •Patients with hilar liver lesions
结局指标
主要结局
MR Images
时间窗: 6 months
次要结局
未报告次要终点
研究者
David A. Woodrum
Assistant Professor of Radiology
Mayo Clinic
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver MetastasisCarcinoma, HepatocellularLiver NeoplasmsDigestive System NeoplasmsNCT00392366BioTex, Inc.25
已完成
不适用
Laser Based Focal Ablation of Low Grade Prostate CancerLow Grade Prostate CancerNCT01192438University of Chicago9
进行中（未招募）
3 期
Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)Primary GlioblastomaNCT05318612Radboud University Medical Center238
进行中（未招募）
1 期
LITT Combined With Early Use of Temozolomide for Recurrent GlioblastomasRecurrent GlioblastomaNCT05663125Beijing Tiantan Hospital10
已完成
不适用
MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate CancerStage I Prostate CancerStage II Prostate CarcinomaNCT01792024University of Chicago27